Trial Profile
A Phase II Open and Parallel Safety, Immunogenicity and Reactogenicity Trial of Mencevax ACW135 Polysaccharide Vaccine Comparing Three Groups: 2 - 4 Year, 5 - 14 Year and 15 - 29 Year Old Ethiopians.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Jan 2010
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C W-135 polysaccharide (Primary) ; Meningococcal vaccine groups A C Y W-135 polysaccharide
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms ETH-TVT
- 21 Oct 2009 New trial record